# Equifax Inc: overview

EFX · NYSE · CIK 33185 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/efx.md) · [Financials](/companies/efx/financials.md) · [Filings](/companies/efx/filings.md) · [Insiders](/companies/efx/insiders.md)

Latest reported revenue: [$1.69bn](/filings/0000033185-26-000044.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 20, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000033185-26-000044).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,419 d](/filings/0000033185-26-000010.md) | [1,442](/filings/0000033185-26-000018.md) | [1,537](/filings/0000033185-26-000028.md) | [1,545](/filings/0000033185-26-000044.md) | [1,551 d](/filings/0000033185-26-000010.md) | [1,649](/filings/0000033185-26-000018.md) | [1,700](/filings/0000033185-26-000028.md) | [1,693](/filings/0000033185-26-000044.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [20.3% d](/filings/0000033185-26-000010.md) | [16.4%](/filings/0000033185-26-000018.md) | [20.2%](/filings/0000033185-26-000028.md) | [17.1%](/filings/0000033185-26-000044.md) | [18.3% d](/filings/0000033185-26-000010.md) | [17.4%](/filings/0000033185-26-000018.md) | [18.5%](/filings/0000033185-26-000028.md) | [21.0%](/filings/0000033185-26-000044.md) |
| Net margin | % | [12.3% d](/filings/0000033185-26-000010.md) | [9.2%](/filings/0000033185-26-000018.md) | [12.4%](/filings/0000033185-26-000028.md) | [10.4%](/filings/0000033185-26-000044.md) | [11.3% d](/filings/0000033185-26-000010.md) | [10.4%](/filings/0000033185-26-000018.md) | [10.8%](/filings/0000033185-26-000028.md) | [12.5%](/filings/0000033185-26-000044.md) |
| Diluted EPS | $ per share | not reported | [1.06](/filings/0000033185-26-000018.md) | [1.53](/filings/0000033185-26-000028.md) | [1.29](/filings/0000033185-26-000044.md) | not reported | [1.42](/filings/0000033185-26-000018.md) | [1.54](/filings/0000033185-26-000028.md) | [1.79](/filings/0000033185-26-000044.md) |
| Free cash flow | $m | [206 d](/filings/0000033185-26-000010.md) | [117](/filings/0000033185-26-000018.md) | [239 d](/filings/0000033185-26-000028.md) | [438 d](/filings/0000033185-26-000044.md) | [341 d](/filings/0000033185-26-000010.md) | [122](/filings/0000033185-26-000018.md) | [205 d](/filings/0000033185-26-000028.md) | [437 d](/filings/0000033185-26-000044.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4,924](/filings/0000033185-24-000017.md) | [5,122](/filings/0000033185-25-000025.md) | [5,265](/filings/0000033185-26-000010.md) | [5,681](/filings/0000033185-26-000010.md) | [6,075](/filings/0000033185-26-000010.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [23.1%](/filings/0000033185-24-000017.md) | [20.6%](/filings/0000033185-25-000025.md) | [17.7%](/filings/0000033185-26-000010.md) | [18.3%](/filings/0000033185-26-000010.md) | [18.0%](/filings/0000033185-26-000010.md) |
| Net margin | % | [15.1%](/filings/0000033185-24-000017.md) | [13.6%](/filings/0000033185-25-000025.md) | [10.4%](/filings/0000033185-26-000010.md) | [10.6%](/filings/0000033185-26-000010.md) | [10.9%](/filings/0000033185-26-000010.md) |
| Diluted EPS | $ per share | [6.02](/filings/0000033185-24-000017.md) | [5.65](/filings/0000033185-25-000025.md) | [4.40](/filings/0000033185-26-000010.md) | [4.84](/filings/0000033185-26-000010.md) | [5.32](/filings/0000033185-26-000010.md) |
| Free cash flow | $m | [866](/filings/0000033185-24-000017.md) | [133](/filings/0000033185-25-000025.md) | [516](/filings/0000033185-26-000010.md) | [813](/filings/0000033185-26-000010.md) | [1,134](/filings/0000033185-26-000010.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/efx/insiders.md)

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-23 | [Begor Mark W](/insiders/1335111.md) | CEO, Director, Officer | Sale (S) | 33,667 | $182.517 | $6.1m | [Form 4](/filings/0001225208-26-008522.md) |
| 2026-10-23 | [Begor Mark W](/insiders/1335111.md) | CEO, Director, Officer | Sale (S) | 1,681 | $185.2034 | $311.3k | [Form 4](/filings/0001225208-26-008522.md) |
| 2026-10-23 | [Begor Mark W](/insiders/1335111.md) | CEO, Director, Officer | Sale (S) | 1,250 | $183.403 | $229.3k | [Form 4](/filings/0001225208-26-008522.md) |
| 2026-10-23 | [Begor Mark W](/insiders/1335111.md) | CEO, Director, Officer | Sale (S) | 1,194 | $186.7335 | $223.0k | [Form 4](/filings/0001225208-26-008522.md) |

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.49bn | 9,396,150 |  | Reduced −65,798 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $1.23bn | 7,780,433 |  | Reduced −44,672 |
| [HARRIS ASSOCIATES L P](/funds/813917.md) | 2026-06-30 | $1.18bn | 7,447,263 |  | Reduced −81,853 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $832.1m | 5,242,614 |  | Reduced −28,390 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $825.3m | 5,199,595 |  | Added +176,003 |
| [Capital International Investors](/funds/1562230.md) | 2026-06-30 | $823.3m | 5,187,147 |  | Added +1,510,205 |
| [Soroban Capital Partners LP](/funds/1517857.md) | 2026-06-30 | $700.1m | 4,410,883 |  | Added +226,314 |
| [MASSACHUSETTS FINANCIAL SERVICES CO /MA/](/funds/912938.md) | 2026-06-30 | $620.4m | 3,869,490 |  | Reduced −830,420 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $525.5m | 3,310,957 |  | Reduced −705,458 |
| [BROWN ADVISORY INC](/funds/1345929.md) | 2026-06-30 | $521.9m | 3,287,984 |  | Reduced −360,835 |

## Recent filings

[All 1,741 filings](/companies/efx/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-20 | 16:17 ET | [10-Q](/filings/0000033185-26-000044.md) | Quarterly report, period 2026-09-30 | 0000033185-26-000044 |
| 2026-10-20 | 06:31 ET | [8-K](/filings/0000033185-26-000037.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000033185-26-000037 |
| 2026-07-29 | 16:15 ET | [8-K](/filings/0001193125-26-323760.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-323760 |
| 2026-07-21 | 16:39 ET | [10-Q](/filings/0000033185-26-000028.md) | Quarterly report, period 2026-06-30 | 0000033185-26-000028 |
| 2026-07-21 | 06:32 ET | [8-K](/filings/0000033185-26-000024.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000033185-26-000024 |
| 2026-06-16 | 16:46 ET | [8-K](/filings/0001193125-26-272759.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-272759 |
| 2026-05-13 | 21:52 ET | [8-K](/filings/0001193125-26-220328.md) | 5.07 Shareholder vote results | 0001193125-26-220328 |
| 2026-04-24 | 17:05 ET | [8-K](/filings/0001193125-26-177620.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-177620 |
| 2026-04-21 | 16:30 ET | [10-Q](/filings/0000033185-26-000018.md) | Quarterly report, period 2026-03-31 | 0000033185-26-000018 |
| 2026-04-21 | 06:32 ET | [8-K](/filings/0000033185-26-000016.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000033185-26-000016 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000033185-26-000010.md), filed Feb 19, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 33185
- Tickers: EFX
- Exchange: NYSE
- SIC code: 7320 Services-Consumer Credit Reporting, Collection Agencies
- State of incorporation: GA
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 09:48 ET. No prices; not investment advice.